The United States of America;as represented by the Secretary;Department of Health and Human Services
发明人:
Jeffrey Schlom,James W. Hodge
申请号：
US16686390
公开号：
US20200140567A1
申请日:
2019.11.18
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention is directed to methods of reducing growth of prostate cancer cells and breast cancer cells, which comprises treating such cancer cells with a combination of androgen or endocrine deprivation therapy (e.g., enzalutamide, abiraterone, and tamoxifen) and immunotherapy.
